Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss

被引:22
作者
Nocera, A. [1 ]
Tagliamacco, A. [1 ]
Cioni, M. [2 ]
Innocente, A. [3 ]
Fontana, I. [4 ]
Barbano, G. [2 ]
Carrea, A. [2 ]
Ramondetta, M. [3 ]
Sementa, A. [5 ]
Basso, S. [6 ]
Quartuccio, G. [6 ]
Klersy, C. [7 ]
Bertocchi, M. [4 ]
Verrina, E. [2 ]
Garibotto, G. [8 ]
Ghiggeri, G. M. [2 ]
Cardillo, M. [3 ]
Comoli, P. [6 ]
Ginevri, F. [2 ]
机构
[1] Univ Genoa, Transplant Immunol Res Lab, Clin Nephrol Unit, Dept Internal Med DIMI, Genoa, Italy
[2] G Gaslini Inst Children, Nephrol Dialysis & Transplantat Unit, Genoa, Italy
[3] Fdn Ca Granda Osped Maggiore Policlin, Transplantat Immunol, Milan, Italy
[4] IRCCS Azienda Osped Univ S Martino Ist Nazl Ric C, Kidney Transplant Surg Unit, Genoa, Italy
[5] Ist Giannina Gaslini, Pathol Unit, Genoa, Italy
[6] Fdn Policlin S Matteo, Pediat Hematol Oncol, Pavia, Italy
[7] Fdn Policlin S Matteo, Biometry & Stat Serv, Pavia, Italy
[8] Univ Genoa, Dept Internal Med, Nephrol Unit, Genoa, Italy
关键词
RENAL-TRANSPLANT RECIPIENTS; HUMORAL REJECTION; RISK; COMPLEMENT; ALLOANTIBODIES; PATHOLOGY; OUTCOMES; FAILURE; LESIONS; C1Q;
D O I
10.1111/ajt.14000
中图分类号
R61 [外科手术学];
学科分类号
摘要
Donor-specific HLA antibody (DSA)-mediated graft injury is the major cause of kidney loss. Among DSA characteristics, graft homing has been suggested as an indicator of severe tissue damage. We analyzed the role of de novo DSA (dnDSA) graft homing on kidney transplantation outcome. Graft biopsy specimens and parallel sera from 48 nonsensitized pediatric kidney recipients were analyzed. Serum samples and eluates from graft biopsy specimens were tested for the presence of dnDSAs with flow bead technology. Intragraft dnDSAs (gDSAs) were never detected in the absence of serum dnDSAs (sDSAs), whereas in the presence of sDSAs, gDSAs were demonstrated in 72% of biopsy specimens. A significantly higher homing capability was expressed by class II sDSAs endowed with high mean fluorescence intensity and C3d-and/or C1q-fixing properties. In patients with available sequential biopsy specimens, we detected gDSAs before the appearance of antibody-mediated rejection. In sDSA-positive patients, gDSA positivity did not allow stratification for antibody-mediated graft lesions and graft loss. However, a consistent detection of skewed unique DSA specificities was observed over time within the graft, likely responsible for the damage. Our results indicate that gDSAs could represent an instrumental tool to identify, among sDSAs, clinically relevant antibody specificities requiring monitoring and possibly guiding patient management.
引用
收藏
页码:692 / 702
页数:11
相关论文
共 38 条
[1]   Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies [J].
Arnold, Marie-Luise ;
Ntokou, Irma-Sofia ;
Doxiadis, Ilias I. . N. ;
Spriewald, Bernd M. ;
Boletis, John N. ;
Iniotaki, Aliki G. .
TRANSPLANT INTERNATIONAL, 2014, 27 (03) :253-261
[2]   Kidney Intragraft Donor-Specific Antibodies as Determinant of Antibody-Mediated Lesions and Poor Graft Outcome [J].
Bachelet, T. ;
Couzi, L. ;
Lepreux, S. ;
Legeret, M. ;
Pariscoat, G. ;
Guidicelli, G. ;
Merville, P. ;
Taupin, J-L .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (11) :2855-2864
[3]   Antibody-mediated organ-allograft rejection [J].
Colvin, RB ;
Smith, RN .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (10) :807-817
[4]   Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients [J].
Comoli, P. ;
Cioni, M. ;
Tagliamacco, A. ;
Quartuccio, G. ;
Innocente, A. ;
Fontana, I. ;
Trivelli, A. ;
Magnasco, A. ;
Nocco, A. ;
Klersy, C. ;
Rubert, L. ;
Ramondetta, M. ;
Zecca, M. ;
Garibotto, G. ;
Ghiggeri, G. M. ;
Cardillo, M. ;
Nocera, A. ;
Ginevri, F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (07) :2106-2116
[5]   Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation [J].
DeVos, Jennifer M. ;
Gaber, A. Osama ;
Knight, Richard J. ;
Land, Geoffrey A. ;
Suki, Wadi N. ;
Gaber, Lillian W. ;
Patel, Samir J. .
KIDNEY INTERNATIONAL, 2012, 82 (05) :598-604
[6]  
Dijke IE, 2016, J HEART LUNG TRANSPL, DOI [10.1016/j.healun.2016.01.1232, DOI 10.1016/J.HEALUN.2016.01.1232]
[7]   Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation [J].
Dunn, T. B. ;
Noreen, H. ;
Gillingham, K. ;
Maurer, D. ;
Ozturk, O. G. ;
Pruett, T. L. ;
Bray, R. A. ;
Gebel, H. M. ;
Matas, A. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (10) :2132-2143
[8]   Identifying Specific Causes of Kidney Allograft Loss [J].
El-Zoghby, Z. M. ;
Stegall, M. D. ;
Lager, D. J. ;
Kremers, W. K. ;
Amer, H. ;
Gloor, J. M. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (03) :527-535
[9]   Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients [J].
Fichtner, Alexander ;
Suesal, Caner ;
Hoecker, Britta ;
Rieger, Susi ;
Waldherr, Ruediger ;
Westhoff, Jens H. ;
Sander, Anja ;
Opelz, Gerhard ;
Toenshoff, Burkhard .
PEDIATRIC NEPHROLOGY, 2016, 31 (07) :1157-1166
[10]   Humoral Immune Response and Allograft Function in Kidney Transplantation [J].
Filippone, Edward J. ;
Farber, John L. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (02) :337-347